Vaccination publications

FIP’s publications in this area range from the FIP-WHO Good Pharmacy Practice guidelines (2011) to advocacy tools, global data, guidelines and practice support tools. They include a members-only advocacy toolkit to support member organisations’ advocacy for the implementation of pharmacy-based vaccination, a collection of evidence and guidelines for the development of vaccination services, survey reports on the evolving roles of pharmacy in vaccination, and a regulatory self-evaluation assessment tool for advancing pharmacy services in this area.

Publications are presented in chronological order, from more recent to older. Please scroll down inside the grey area or using the scroll bar on its side to find more FIP publications.

FIP Global Vaccination Summit 2025 - Key outcomes and policy recommendations for pharmacy-based vaccination

Building on the success of the inaugural summit in 2024, key discussions and outcomes from the 2025 FIP Global Vaccination Summit, are shared in this report. The summit focused on expanding pharmacist-led vaccination services and supporting equitable access to immunisation through pharmacy practice. Structured around four strategic pillars — workforce and education, policy and regulation, service delivery, and public trust and uptake — the report highlights key insights, challenges, and recommended actions that emerged from the event. Access is available exclusively to FIP member organisations.

FIP knowledge and skills reference guide for professional development in vaccination services (2025)

This guide reinforces FIP’s commitment to supporting pharmacists in their role in vaccination. It builds on existing FIP data and resources to enhance pharmacists’ training and education in pharmacy-based vaccination. It outlines the key knowledge and skills that pharmacists need to meet the evolving demands of healthcare systems and public health needs, serving as a useful guide for practitioners, educators, students, and regulators.

Communication guide on HPV Vaccine and HPV-related diseases

This FIP communication guide supports pharmacists in starting conversations about human papillomavirus (HPV) vaccine & HPV-related diseases. The guide provides evidence-based information to address common concerns, promote HPV vaccination effectively, and raise awareness about cervical cancer.

Global vaccination policy development summit - Executive summary (2024)

In April 2024, FIP hosted a policy development summit to focus on the growing role of pharmacy in vaccinations and to describe and define the parameters for implementing the FIP global policy on life course immunisation. This report summarises the insights, data, expertise and experiences shared during the summit and is a foundational document for the development of a policy framework for life course immunisation globally. This summit represented the first step in delivering this framework.

Leveraging pharmacy to deliver life-course vaccination: An FIP global intelligence report - Executive summary (2024)

As more countries authorize pharmacists to deliver vaccines, FIP remains committed to supporting pharmacists in this vital role and advocating for the widespread use of pharmacists in ensuring vaccination coverage and improving the health care system. A comprehensive overview of pharmacist-led vaccination services around the world is presented in this executive summary, which is open access.

Leveraging pharmacy to deliver life-course vaccination: An FIP global intelligence report (2024)

Recent years have seen pharmacists’ roles in immunization evolve significantly, with increased access to administer vaccines across regions. Based on a cumulative dataset of 120 countries, this report evaluates many aspects of pharmacist-led vaccination. These include advocacy activities, regulatory frameworks, vaccination administration and prescribing, training, certification, access to vaccination records, remuneration models and identifying barriers to extending these services. This study forms part of the FIP Vaccination Surveillance Project, an ongoing initiative aimed at continuously monitoring and assessing the development of pharmacists’ roles in immunization globally.

Advancing pharmacy practices in vaccination: Preparing for winter. Report from a FIP insight board (2024)

This report, resulting from an insight board that FIP hosted in October 2023, aims to shed light on the multifaceted approach undertaken by pharmacies to meet the increased demand for immunisations during winter, considering factors such as vaccine availability, staff training, public awareness campaigns and collaborative efforts with healthcare stakeholders. At the insight board, experts in the field of immunisation discussed vaccination and preparing for winter and shared valuable insights for pharmacists, healthcare professionals, policymakers and the general public to better understand and appreciate the vital role of pharmacies in increasing uptake of different vaccines, especially during winter periods.

Advancing pharmacy practices in vaccination: Reaching at-risk and vulnerable groups. Report from a FIP insight board (2024)

During an insight board hosted by FIP in October 2023, experts in pharmacy and immunisation joined to discuss ways of improving vaccination for at-risk and vulnerable population groups. This report provides a summary of the insight board discussion as well as the key insights that were shared.

Advancing pharmacy practices in vaccination: Unlocking vaccine confidence. Report from a FIP insight board (2024)

FIP, being the leader of pharmacy globally, continues to expand its presence within pharmacy and pharmaceutical sciences, and to influence policymaking, education and science institutions to become better. As part of its efforts on vaccination, FIP hosted an insight board in October 2023 exploring the factors that affect vaccine confidence and public trust in vaccines as well as the strategies that optimise vaccine acceptance.

Vaccination: Benefits beyond specific diseases prevention. Summaries from the FIP digital events programme (2023)

This report provides a summary of the outcomes of two of the events that mostly took part as panel discussions (Part 3 and Part 4), highlighting key insights from panel discussions that showcased the burden of diseases and the risks and costs of not widening access to vaccination as well as the key role that pharmacists can play in life course immunisation.

Statement of policy on the role of pharmacy in life-course vaccination

Pharmacists are uniquely positioned to support the vaccination of various population groups and to remove barriers to achieving high vaccination coverage rates, including hard-to-reach or high-risk population groups. This statement discusses the importance of integrating pharmacists into expanded vaccination schedules and strategies beyond infancy to ensure access to vaccines for all age groups, including adults and older persons. It also discusses the important role of pharmacists in building vaccine confidence and addressing vaccine hesitancy.

Pharmacy-based vaccination: Recent developments, success stories and implementation challenges (2023)

This report provides an update in terms of qualitative insights on recent developments and success stories of pharmacy-based vaccination in several countries, as well as an overview of some of the challenges that some countries are still facing to introduce this valuable professional service by pharmacists. The report also aims to uphold FIP’s global and regional advocacy of vaccination-related roles by pharmacists, and to provide FIP member organisations with examples that can support their own process and advocacy. The report includes a compilation of 17 case studies and country updates by FIP member organisations from countries with remarkable recent developments in this area, followed by the report from an insight board (focus group) discussion with countries that are at different stages of introducing pharmacy-based vaccination or that are facing specific challenges to achieve this goal.

Supporting life-course immunisation through pharmacy-based vaccination: enabling equity, access and sustainability. A toolkit for pharmacists (2023)

Health equity is only achieved when there are no differences in the quality of and access to health care among all groups and at all ages in a society. Whether to an infant, a child, a young adult, or an older adult, the quality of health care should not change. Similarly, access to care should not vary throughout an individual’s life. Because inequities are cumulative, their impacts are not confined to one stage of an individual’s life but rather remain and affect a person’s
life years afterwards. In addition, the impacts are not restricted to a particular individual, but can affect the lives of those around. Vaccine inequities, too, especially among people of different ages, have a cumulative effect. Inequitable access to vaccines not only leaves people at risk of contracting and spreading deadly viruses but also leads to more virus variants emerging, affecting a whole population, even those vaccinated.

Crear confianza en las vacunas y comunicar su valor: Guia para farmacéuticos (2021)

Esta publicación identifica motivos comunes de preocupación o vacilación relacionados con la seguridad y eficacia de las vacunas y propone enfoques efectivos para abordarlos de diversas maneras a través de campañas dirigidas por farmacias y mediante interacciones con pacientes individuales.

Videos: Vaccines and special-risk population groups

While vaccines are recommended for almost everyone, there are specific groups of people who may be particularly vulnerable to severe forms of vaccine-preventable diseases. Their health conditions may increase the risk of developing complications requiring hospitalisation, developing secondary illnesses or even dying. Therefore, it is imperative to actively promote vaccination to those groups to ensure that they receive all the vaccines that are suitable for their age and clinical situation. Pharmacists can play an important role in promoting and advocating vaccination to these groups by leveraging their accessibility, expertise and trust by the population. Their frequent interactions with the public provide valuable opportunities to raise awareness of the importance of vaccination.

Vaccination of special-risk groups: A toolkit for pharmacists (2022)

Pharmacists are one of the most easily accessible healthcare professionals, and they are increasingly engaged in primary healthcare strategies, including disease prevention. Pharmacists are key healthcare professionals  to support  specific population groups who are more vulnerable to severe forms of vaccine-preventable diseases and have a higher risk of hospitalisation, loss of functional ability and even death. These special-risk groups must be the target of proactive and systematic actions by healthcare professionals to ensure they are vaccinated against all diseases that may impact their health in a severe and largely preventable way.

Optimising vaccination through coadministration of influenza and COVID-19 vaccines: Guidance for pharmacists (2022)

This new guidance for pharmacists explores how vaccination strategies for two important respiratory conditions — COVID-19 and influenza — can and should be considered together and combined in an effective and impactful way to improve uptake rates for each vaccine.

The FIP vaccination reference guide. Knowledge and skills to support professional development and inform pharmacy education in vaccination (2022)

Pharmacists in many parts of the world play key roles in public health, including vaccination-related services. As
established advocates, educators and qualified providers of vaccines, pharmacists have a significant role in promoting
and supporting the uptake and monitoring of vaccination. Their roles include raising awareness of the benefits of
vaccination and improving immunisation coverage. To successfully deliver these important roles, pharmacists need to
obtain the required knowledge and skills in the area of vaccination.

“FIP vaccination reference guide: Knowledge and skills in pharmacy education and professional development” is
developed by FIP for educators and academic institutions, practitioners and professional organisations, and
policymakers. The reference guide outlines the knowledge and skills that should be acquired by students during their
undergraduate pharmacy education, and expands into the knowledge and skills that should be obtained by pharmacists
through professional development and training.

Construir a confiança nas vacinas e comunicar o seu valor. Um manual para farmacêuticos. (2021)

Esta publicação identifica razões comuns de preocupação ou hesitação relacionadas com a segurança e eficácia das vacinas e propõe abordagens eficazes para as abordar de diversas formas através de campanhas lideradas pelas farmácias e através de interacções com pacientes individuais.

Advocating expansion of the pharmacist’s role in immunisation: A focus on diphtheria-tetanus-pertussis booster, COVID-19 and meningitis vaccinations (2022)

Pharmacists are contributing to expanded immunisation coverage globally, thereby reducing illness and deaths from vaccine-preventable diseases. The report provides intelligence on the current status of these services in 36 countries that have regulated pharmacy-based vaccination services to identify pharmacists’ current role in DTP booster vaccination, COVID vaccination and meningococcal meningitis vaccination. The new data shows that their role has expanded since the publication of a previous FIP report in 2020. This increase has been driven in part by the need for urgent and mass vaccination as a result of the COVID-19 pandemic, the report authors say. In addition, vaccination authority policy development, stakeholder engagement and acceptance of pharmacists’ role, logistics development, and education and training were highlighted as being necessary if pharmacists’ role in vaccination services is to be leveraged further.

FIP commitment to leveraging pharmacists to build vaccine confidence and address vaccine hesitancy and complacency (2022)

Vaccine hesitancy – concerns related to vaccination or outright refusal to receive vaccines despite availability – is a major threat to global health and an important barrier to the success of vaccination strategies worldwidei. Barriers such as misinformation and distrust in vaccines can compromise not only the health of individuals but also public health as a whole.

The International Pharmaceutical Federation (FIP), which brings together 146 organisations of pharmacists, pharmaceutical scientists and pharmaceutical educators, and represents over four million pharmacists from around the world, believes it is essential that pharmacy and other civil society organisations join forces and outline synergistic and complementary advocacy actions for broader access to and convenience of vaccination services through a diversity of providers and pathways, and to address vaccine hesitancy from multiple perspectives.

The commitment is available in the following languages:

Programme de vaccination contre la pandèmie en pharmacie: Un outil d'auto-évaluation des politiques (2021)

Cet outil d’auto-évaluation permettra d’identifier les points forts et les domaines à améliorer afin d’informer les efforts de planification pandémique avant les vagues actuelles et futures de COVID-19. Il s’agit d’un outil destiné à aider les ministères de la santé et les organismes de réglementation nationaux à évaluer la préparation à la pandémie et l’état de la législation et de la réglementation dans leur pays afin de faciliter la vaccination et le dépistage de masse et d’améliorer les soins aux patients par le biais des pharmaciens et des pharmacies communautaires.

Good Pharmacy Practice – Joint FIP/WHO Guidelines on GPP Standards for quality of pharmacy services (2011)

This document describes the key roles, functions and activities of pharmacists, including the administration of vaccines.

An overview of current pharmacy impact on immunisation. A global report (2016)

This publication reports the findings of the first FIP survey on the roles of pharmacists in vaccination, conducted in 2016.

An overview of pharmacy's impact on immunisation coverage. A global survey (2020)

This report contains the findings of FIP’s latest survey (2020) of pharmacy’s impact on immunisation coverage. It evaluates different aspects of pharmacist-led immunisation, including advocacy and awareness activities, regulatory frameworks, vaccine administration, reimbursement models, training and certification, vaccination records, and limitations and barriers to the expansion of pharmacy practice to include vaccine administration. A total of 99 countries and territories participated, making this the most comprehensive report published on this subject to date.

FIP Vaccination Handbook for Pharmacists (2021)

With this publication, FIP aims to support individual pharmacists with understanding how they can contribute to improving vaccination coverage through services ranging from patient education and advice, to logistical roles and the administration of vaccines. This handbook provides guidance on the practical implementation of these services and includes guidelines on the procedures, safety aspects, common risk points and frequently asked questions about vaccines and their administration.

Building vaccine confidence and communicating vaccine value: A toolkit for pharmacists (2021)

This publication identifies common reasons for concern or hesitancy related to vaccine safety and efficacy and proposes effective approaches to address them in a variety of ways through pharmacy-led campaigns and through interactions with individual patients.

Good Pharmacy Practice – Joint FIP/WHO Guidelines on GPP Standards for quality of pharmacy services

This document describes the key roles, functions and activities of pharmacists, including the administration of vaccines.

FIP call to action to expand the role of community pharmacies in vaccination, including against COVID-19 and future pandemic (2020)

This statement highlights the role of pharmacists in vaccination and in the promotion of vaccination coverage around the world.